PMID- 25856540
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20221207
IS  - 1365-2060 (Electronic)
IS  - 0785-3890 (Print)
IS  - 0785-3890 (Linking)
VI  - 47
IP  - 3
DP  - 2015 May
TI  - Associations between sleep disturbances and diabetes mellitus among blacks with 
      metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO).
PG  - 233-7
LID - 10.3109/07853890.2015.1015601 [doi]
AB  - INTRODUCTION: The association between sleep disturbances and cardiometabolic 
      diseases has been understudied in blacks with metabolic syndrome. METHODS: This 
      study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study 
      (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep 
      apnea. Multivariate logistic regression models evaluated the association between 
      sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM 
      and hypertension as well as DM and dyslipidemia. RESULTS: The sample consisted of 
      1,013 participants, mean age of 62 +/- 14 years and 61% female. DM was diagnosed in 
      60% of the sample. Sleep apnea risk was observed in 48% of the sample, while 10% 
      had insomnia symptoms and 65% reported short sleep duration (< 6 hours). Sleep 
      apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 
      95% CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI >/= 30 kg/m(2)), 
      tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully 
      adjusted models, sleep apnea risk was associated with the combined outcome of 
      DM-hypertension (OR 1.95; 95% CI 1.42-2.69), but not with diabetes-dyslipidemia. 
      CONCLUSION: We observed a strong association between sleep apnea risk and 
      diabetes mellitus among blacks with metabolic syndrome.
FAU - Ramos, Alberto R
AU  - Ramos AR
AD  - Department of Neurology, Miller School of Medicine, University of Miami , Miami , 
      FL, USA.
FAU - Wallace, Douglas M
AU  - Wallace DM
FAU - Pandi-Perumal, Seithikurippu Ratnas
AU  - Pandi-Perumal SR
FAU - Williams, Natasha J
AU  - Williams NJ
FAU - Castor, Chimene
AU  - Castor C
FAU - Sevick, Mary Ann
AU  - Sevick MA
FAU - Mcfarlane, Samy I
AU  - Mcfarlane SI
FAU - Jean-Louis, Girardin
AU  - Jean-Louis G
LA  - eng
SI  - ClinicalTrials.gov/NCT01946659
GR  - R01MD004113/MD/NIMHD NIH HHS/United States
GR  - R25 HL116378/HL/NHLBI NIH HHS/United States
GR  - KL2 TR000461/TR/NCATS NIH HHS/United States
GR  - R01 MD004113/MD/NIMHD NIH HHS/United States
GR  - 1KL2TR000461/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150409
PL  - England
TA  - Ann Med
JT  - Annals of medicine
JID - 8906388
SB  - IM
MH  - Black or African American/statistics & numerical data
MH  - Aged
MH  - Cross-Sectional Studies
MH  - Depression/diagnosis/epidemiology
MH  - Diabetes Complications/epidemiology/ethnology
MH  - Diabetes Mellitus/diagnosis/*epidemiology/ethnology
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Metabolic Syndrome/diagnosis/*epidemiology/ethnology
MH  - Middle Aged
MH  - Obesity/epidemiology
MH  - Outcome Assessment, Health Care
MH  - Risk Factors
MH  - Sleep Wake Disorders/diagnosis/*epidemiology/ethnology/metabolism
MH  - United States/epidemiology
PMC - PMC4659349
MID - NIHMS738668
OTO - NOTNLM
OT  - Black race/ethnicity
OT  - diabetes mellitus
OT  - metabolic syndrome
OT  - sleep apnea
COIS- Competing Interest/Disclosure Statement The authors declared no potential 
      conflicts of interest with respect to the financial, research, authorship, and/or 
      publication of this article.
EDAT- 2015/04/10 06:00
MHDA- 2016/02/13 06:00
PMCR- 2015/11/25
CRDT- 2015/04/10 06:00
PHST- 2015/04/10 06:00 [entrez]
PHST- 2015/04/10 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
PHST- 2015/11/25 00:00 [pmc-release]
AID - 10.3109/07853890.2015.1015601 [doi]
PST - ppublish
SO  - Ann Med. 2015 May;47(3):233-7. doi: 10.3109/07853890.2015.1015601. Epub 2015 Apr 
      9.